PASSAGE BIO, INC. Cash and Restricted Cash
PASSAGE BIO, INC. (PASG) had Cash and Restricted Cash of $24.16 million as of 2026-06-30, per its S-4/A filed 2026-09-03.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-09-03
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $24.16M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $33.34M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $46.30M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $52.77M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $24.16M S-4/A · filed 2026-09-03 |
| 2026-03-31 | $33.34M S-4 · filed 2026-07-21 |
| 2025-12-31 | $46.30M S-4/A · filed 2026-09-03 |
| 2025-09-30 | $52.77M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $57.63M S-4/A · filed 2026-09-03 |
| 2025-03-31 | $63.36M S-4 · filed 2026-07-21 |
| 2024-12-31 | $37.57M S-4/A · filed 2026-09-03 |
| 2024-09-30 | $32.29M 10-Q · filed 2025-11-10 |
| 2024-06-30 | $24.77M 10-Q · filed 2025-08-12 |
| 2024-03-31 | $36.77M 10-Q · filed 2025-05-13 |
| 2023-12-31 | $21.71M S-4/A · filed 2026-09-03 |
| 2023-09-30 | $33.58M 10-Q · filed 2024-11-13 |
| 2023-06-30 | $30.29M 10-Q · filed 2024-08-08 |
| 2023-03-31 | $33.37M 10-Q · filed 2024-05-14 |
| 2022-12-31 | $34.60M 10-K · filed 2025-03-04 |
| 2022-09-30 | $62.57M 10-Q · filed 2023-11-13 |
| 2022-06-30 | $91.13M 10-Q · filed 2023-08-07 |
| 2022-03-31 | $101.61M 10-Q · filed 2023-05-11 |
| 2021-12-31 | $128.97M 10-K · filed 2024-03-04 |
| 2021-09-30 | $162.89M 10-Q · filed 2022-11-10 |
| 2021-06-30 | $215.46M 10-Q · filed 2022-08-04 |
| 2021-03-31 | $249.52M 10-Q · filed 2022-05-16 |
| 2020-12-31 | $135.00M 10-K · filed 2023-03-06 |
| 2020-09-30 | $200.57M 10-Q · filed 2021-11-04 |
| 2020-06-30 | $353.42M 10-Q · filed 2021-08-05 |
| 2020-03-31 | $366.83M 10-Q · filed 2021-05-05 |
| 2019-12-31 | $158.87M 10-K · filed 2022-03-03 |
| 2019-09-30 | $177.19M 10-Q · filed 2020-11-10 |
| 2019-06-30 | $78.79M 10-Q · filed 2020-08-13 |
| 2019-03-31 | $43.92M 10-Q · filed 2020-05-11 |
| 2018-12-31 | $24.86M 10-K · filed 2021-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |